Single Pass, Inc. appears in FDA premarket notification records as the applicant for electrosurgical devices regulated under 21 CFR 878.4400, the regulation for electrosurgical cutting and coagulation devices and accessories, in Class II and product code GEI. The supplied filings place the company in the General, Plastic Surgery review panel for its 2026 clearances. The documented product line spans the Kronos Electrocautery Device and the SP Electrocautery Device family, with model designations SP18 Max, SP20 Max and SP20. The supplied collection contains one linked 510(k) record, K262720, decided Substantially Equivalent on October 26, 2026; that count reflects the retrieved snapshot of filings, not total company sales, total portfolio or safety performance. [1][2][3][5]
Documented 510(k) clearances and submission dates
K262720 covers the SP Electrocautery Device (SP18 Max) and SP Electrocautery Device (SP20 Max). FDA received the submission on July 31, 2026, and recorded a Substantially Equivalent decision on October 26, 2026, under clearance type Traditional, with a Summary statement and no third-party review. The applicant address in that record is in Lake Forest, California, and the listed contact is Ryan Breckenridge. [1][3][4]
K260287 covers the SP Electrocautery Device (SP20). The FDA letter is dated February 24, 2026, with the submission dated January 26, 2026 and received January 29, 2026; it names Greg Geissinger of Geissinger Regulatory Consulting, Inc. as the correspondence contact. The FDA premarket notification entry for K260287 records the same February 24, 2026 decision date and a Substantially Equivalent decision. [2][7]
K232805 covers the Kronos Electrocautery Device. The FDA clearance letter is dated April 25, 2024, with the submission dated September 5, 2023 and received March 17, 2024; it names Bill Colone, CEO, at the Lake Forest, California address. The 510(k) summary in that letter states it was prepared September 5, 2023 and revised February 29, 2024. [5]
Product scope described in the filings
The K260287 summary describes a battery-powered electrocautery instrument used to achieve hemostasis through coagulation of soft tissue in liver, kidney, and lung following percutaneous biopsy. That description is tied to the SP20 device in that filing; the supplied excerpts do not state power source or clinical use for the Kronos device or for the SP18 Max and SP20 Max models. [2]
All three documented devices sit under regulation number 878.4400, classified as electrosurgical cutting and coagulation devices and accessories, device class 2, product code GEI. The K262720 record lists the classification name as Electrosurgical, Cutting & Coagulation & Accessories and the medical specialty as General, Plastic Surgery. [1][3][4]
Applicant identity and regulatory representation
The applicant of record on K262720 is Single Pass, Inc., and the manufacturer column in the Innolitics record for that filing also lists Single Pass, Inc. The K232805 clearance letter and its summary identify Single Pass, Inc. as the submitter, with Bill Colone as CEO and contact. The K260287 letter is addressed to Single Pass, Inc. care of a regulatory consultant. [2][3][5]
The public documents do not identify a parent company, brand owner, website or commercial customer for Single Pass, Inc. Addresses appearing in FDA correspondence and filing records are filing addresses and are not treated here as a verified headquarters. [1][2][5]
How to read the supplied collection
The retrieved portfolio snapshot contains one linked 510(k) record, K262720, with a decision count of one Substantially Equivalent and a sample decision count of one Substantially Equivalent. The sample is the same single record, so the two denominators are identical in this snapshot and neither supports any statement about the company's full filing history or outcomes. [1]
The same snapshot contains no recall records. Absence of recalls in the retrieved sample is not evidence of safety performance, and the public documents contain no postmarket data for these devices. [1]
